Ethyl 3-methyl-1-phenylpyrazole-5-carboxylate, 95.0%, 1g

1-(3-Fluoro-2-methylphenyl)prop-2-en-1-ol, 10g

N-(9-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide hydrate, 98+%, 25g

Acridone-4-carboxylic acid, 95+%, 5g

N-(4-Sulfamoylphenyl)acetamide, 95.0%, 100g

(4-Methylpyridin-3-yl)methanol, 97.0%, 5g

(S)-1-Boc-3-Benzylpiperazine, 95.0%, 1g

4-((Methylcarbamoyl)thio)phenyl methanesulfonate, 95.0%, 100mg

tert-Butyl (R)-(oxiran-2-ylmethyl)carbamate, 98%, 250mg

(4-Carbamoyl-3-fluorophenyl)boronic acid, 95.0%, 5g

N-Methyl-2-morpholinone, 95.0%, 1g

N-(1-(Dimethylamino)propan-2-yl)-2-(pyridin-4-yl)-1H-benzo[d]imidazole-7-carboxamide, 98%, 25mg

Colonna capillare per GC ROTI®Cap-5 MS, 60 m, 0.32 mm, 1.00 µm, 1 Pezzo(i)